MCAZ PVCT GL02 Rev 2 May 2024 PHARMACOVIGILANCE GUIDELINE FOR PHARMACEUTICAL INDUSTRY475 DownloadsDownload Now!Size: 2MB
Read MoreMCAZ-PVCT-GL03-Rev-1_May-2024 Guideline for Pharmacovigilance of COVID 19 Vaccine AEFI Safety Surveillance296 DownloadsDownload Now!Size: 1MBPublished: May 14, 2024
Read MorePVF 109 – Rev 1_May 2024 ADR Consumer reporting form_Landscape171 DownloadsDownload Now!Size: 100KB
Read MorePVF 76 Rev_2 May 2024 Annual Progress Reporting Form201 DownloadsDownload Now!Size: 126KB
Read MoreMCAZ-PVCT- GL01 Rev 1 May 2024 Guidelines For Conducting Good Clinical Practice (GCP) Inspections in Zimbabwe193 DownloadsDownload Now!
Read MoreMCAZ PVCT GL06 Rev 2_November 2023 Pharmacy Guidelines for Investigational Medical Products300 DownloadsDownload Now!Size: 2MB
Read MorePVF83 Rev 1 _Jan 2023 APPLICATION FOR ADDITIONAL INVESTIGATOR (S) CHANGE OF INVESTIGATOR (S) OR ADDITIONAL CLINICAL TRIAL SITES179 DownloadsDownload Now!Size: 129KB
Read MorePVF 82 Rev 1_January 2023 Application for a Clinical Trial Protocol Amendment199 DownloadsDownload Now!Size: 167KB
Read MorePVF 79 Rev_1 September 2022 Joint Declaration By Sponsor And Principal Investigator Concerning Sufficient Funds To Complete Study165 DownloadsDownload Now!Size: 123KB
Read MorePVF 78 Rev 1_January 2023 Recommended Format For Cvs Of Individuals Participating In Clinical Trials241 DownloadsDownload Now!Size: 68KB
Read More